The effect of CYP2C19 gene polymorphism on clinical outcomes in patients with CAD receiving antiplatelet therapy

被引：0
|
作者：
Liu, W. [1 ]
Xi, Z. W. [1 ]
Zhou, Y. J. [1 ]
机构：
[1] Beijing Anzhen Hosp, Caridiol, Beijing, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2017年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P4010
引用
收藏
页码：837 / 837
页数：1
相关论文
共 50 条
  • [31] Frequency of CYP2C19 Polymorphism in Ischemic Patients
    Shawky, A.
    PUBLIC HEALTH GENOMICS, 2018, 21 : 15 - 15
  • [32] THIRTY DAY CLINICAL OUTCOMES FOLLOWING IMPLEMENTATION OF CYP2C19 GENOTYPE-GUIDED DUAL ANTIPLATELET THERAPY
    Klein, Melissa
    Sriramoju, Vindhya B.
    Cervantes, Alexandra
    Varunok, Nicholas
    Madan, Shivanshu
    Weck, Karen
    Lee, Craig
    Stouffer, George
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1196 - 1196
  • [33] The effect of CYP2C19 genotype-guided antiplatelet therapy on outcomes of selective percutaneous coronary intervention patients: an observational study
    Tan, Kai
    Lian, Zhexun
    Shi, Yan
    Wang, Xiaxia
    Yu, Haichu
    Li, Mengwan
    Tian, Jianhui
    Ge, Yiping
    PERSONALIZED MEDICINE, 2019, 16 (04) : 301 - 312
  • [34] The CYP2C19 enzyme polymorphism
    Wedlund, PJ
    PHARMACOLOGY, 2000, 61 (03) : 174 - 183
  • [35] CLINICAL OUTCOMES OF CYP2C19 GENOTYPE GUIDED ANTIPLATELET THERAPY IN PATIENTS ON LONG-TERM CLOPIDOGREL THERAPY AFTER PERCUTANEOUS CORONARY INTERVENTION
    Patel, Rajiv
    Kulick, Natasha
    Winget, Marshall
    Nguyen, Anh
    Venkatesh, Sanjay
    Rossi, Joseph
    Lee, Craig R.
    Stouffer, George A.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 788 - 788
  • [36] IMPACT OF CYP2C19 GENOTYPE ON PREDICTION OF CARDIOVASCULAR EVENTS WITH THE ABCD-GENE SCORE AMONG PATIENTS RECEIVING CYP2C19--GUIDED ANTIPLATELET THERAPY AFTER PCI.
    Thomas, C.
    Franchi, F.
    Rossi, J.
    Beitelshees, A.
    Keeley, E.
    Gong, Y.
    Johnson, J.
    Winget, M.
    Anderson, R.
    Kerensky, R.
    McDonough, C.
    Stouffer, G.
    Angiolillo, D.
    Lee, C.
    Cavallari, L.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 : S68 - S68
  • [37] Clinical Value of CYP2C19 Genetic Testing for Guiding the Antiplatelet Therapy in a Chinese Population
    Shen, De-Liang
    Wang, Bo
    Bai, Jing
    Han, Qing
    Liu, Chuang
    Huang, Xiao-Hui
    Zhang, Jin-Ying
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2016, 67 (03) : 232 - 236
  • [38] Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole
    Klomp, Sylvia D.
    Veringa, Anette
    Alffenaar, Jan-Willem C.
    de Boer, Mark G. J.
    Span, Lambert F. R.
    Guchelaar, Henk-Jan
    Swen, Jesse J.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (07):
  • [39] Genetic Polymorphism Analysis of CYP2C19 in the Han nationality with CAD in Beijing
    Yang, Shengli
    Sun, Yaqin
    Wang, Liang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C267 - C267
  • [40] CYP2C19 Gene Polymorphism in Patients With Myocardial Infarction Who Use Clopidogrel
    Galyavich, A. S.
    Valeeva, D. D.
    Minnetdinov, R. Sh.
    Arkhipova, A. A.
    Akhmetov, I. I.
    Galyavi, R. A.
    KARDIOLOGIYA, 2012, 52 (04) : 20 - 24
12345